The authors hypothesized that SIRT1 inhibition in other cells within the cancer microenvironment (i.e., fibroblasts, endothelial, and immune cells) may have been involved in the tumor‐promoting activity of 9a. This evidence concerns the gene SIRT1 and cancer.